San Diego, CA, United States of America

José Luis Millán

This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Am-Pharma B.v., The Ohio State University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: José Luis Millán. Retrieved from https://idiyas.com/inventor/josé-luis-millán

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Innovator José Luis Millán: Pioneering Advances in Alkaline Phosphatases**

Introduction

José Luis Millán, based in San Diego, CA, is a notable inventor and researcher with three registered patents. His groundbreaking work primarily focuses on chimeric alkaline phosphatase-like proteins, which have significant implications in the medical and pharmaceutical fields.

Latest Patents

Millán's latest patents revolve around improved alkaline phosphatases. These inventions relate to enhanced alkaline phosphatases, their pharmaceutical compositions, and their potential applications in preventing, treating, or curing diseases. His contribution aims to revolutionize therapeutic approaches by utilizing these advanced proteins.

Career Highlights

Throughout his career, Millán has consistently aimed to improve biochemical processes, making strides in the field of enzymology. His commitment to innovation has positioned him as a key figure in the development of pharmaceutical solutions, particularly through his role at Am-Pharma B.V., where he continues to drive research and development initiatives.

Collaborations

Millán collaborates with esteemed colleagues, including Willem Raaben and Luigi Johannes Cornelius Jonk. Their collective expertise enhances the research at Am-Pharma B.V., fostering an environment of innovation and progress that addresses complex health challenges.

Conclusion

José Luis Millán exemplifies the spirit of innovation in the biotechnology sector. His advancements in alkaline phosphatases not only showcase his inventiveness but also hold promise for significant contributions to medical science. As he continues to work with talented professionals in the field, the impact of his inventions will likely resonate well beyond the laboratory, influencing future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…